Recent studies have demonstrated that SOCS3 exhibits significantly elevated expression in monocytes and inflammatory tissues during the acute phase of gout, showing marked differences compared to individuals with normal serum uric acid (SUA) levels or those with asymptomatic hyperuricemia (AH). This evidence concerns the gene SOCS3 and gout.